Axsome Therapeutics
NY - New YorkBiotechnology
Focus: Axsome is a CNS-focused biotech company with a commercial portfolio centered on neurology treatments, anchored by AUVELITY for major depressive disorder. The company is actively scaling its commercial operations while advancing a pipeline of CNS programs.
Profile data last refreshed 8h ago · AI intelligence enriched 1w ago
Open Jobs
101-5 this month
Cooling — net -5 jobs in 30d
53 added, 58 removed. Slower than typical.
Should You Work at Axsome Therapeutics?
AI assessmentBest suited for commercial and sales professionals seeking stability with growth; risky for scientists seeking R&D depth.
Why Work Here
- Established revenue base ($51M from two marketed products) provides salary stability and removes pre-revenue execution risk
- Heavy commercial hiring (108 of 122 roles) signals growth phase and advancement opportunities in sales, marketing, and market access
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Late-stage
16 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$34M Part DStable
Peak17.2yr
Help build intelligence for Axsome Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.